A New Consideration for Corticosteroid Injections: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Vaccination

Ian Powelson; Robert A Kaufmann; Natasha M Chida; Jaimie T Shores

doi:10.1016/j.jhsa.2021.07.002

A New Consideration for Corticosteroid Injections: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Vaccination

J Hand Surg Am. 2022 Jan;47(1):79-83. doi: 10.1016/j.jhsa.2021.07.002. Epub 2021 Jul 16.

Authors

Ian Powelson¹, Robert A Kaufmann², Natasha M Chida³, Jaimie T Shores⁴

Affiliations

¹ Department of Plastic & Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
² Department of Orthopedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA.
³ Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD.
⁴ Department of Plastic & Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: jshores3@jhmi.edu.

Abstract

Corticosteroid injection (CSI) is a commonly used tool in hand surgery that is often given little consideration as a potential detriment to vaccination efficacy. The authors reviewed guidelines issued by relevant societies for the timing of CSI around the severe acute respiratory syndrome coronavirus 2 vaccination period and the evidence used to support them. Ultimately, providers and patients should be adequately educated on the theoretical risks and benefits before proceeding with CSI immediately before, during, or immediately after coronavirus disease 2019 vaccination.

Keywords: COVID; COVID-19; Corticosteroid; SARS-CoV-2; corticosteroid injection; vaccination; vaccine.

Publication types

Review

MeSH terms

Adrenal Cortex Hormones
COVID-19*
Humans
Injections
SARS-CoV-2*
Vaccination

Substances

Adrenal Cortex Hormones